Literature DB >> 30265210

Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling.

Shaling Li1, Huimin Gu1, Yan Huang1, Qian Peng2, Rongrong Zhou1, Panpan Yi1, Ruochan Chen1, Zebing Huang1, Xingwang Hu1, Yun Huang3, Daolin Tang4.   

Abstract

Hepatocellular carcinoma (HCC), one of the most common type of cancers, is highly refractory to most systemic therapies. Understanding the genomic dysregulations, in particularly non-coding RNA (ncRNA) dysregulations, in HCC may provide novel strategies to HCC treatment. In our previous study, we demonstrated the key role of miR-200a-mediated HMGB1/RAGE signaling in HCC carcinogenesis. In the present study, we identified circular RNA (circRNA)-miRNA pair that might modulate the migration of HCC cell lines based on previously reported GEO database (GSE78520 and GSE43445) and investigated the function and molecular mechanism. circRNA-101368 was predicted by lncTar to target miR-200a, and the expression of circRNA-101368 was significantly upregulated in HCC tissue samples; the overexpression of circRNA-101368 was correlated with poorer prognosis in patients with HCC. Moreover, circRNA-101368 knockdown suppressed the migration and the protein levels of HMGB1, RAGE and NF-κB, while increased the E-Cadherin expression in HCC cell lines. As confirmed by luciferase reporter and RNA immunoprecipitation assays, circRNA-101368 directly bound to miR-200a to negatively regulate each other. The effect of circRNA-101368 knockdown on cell migration and HMGB1/RAGE signaling could be partially attenuated by miR-200a inhibition. In tissue samples, miR-200a was negatively correlated with circRNA-101368 and HMGB1, respectively, whereas circRNA-101368 and HMGB1 was positively correlated. Taken together, we demonstrated a network of circRNAs-miRNA-mRNA in HCC and provided a novel mechanism of HCC cell migration regulation.

Entities:  

Keywords:  HMGB1; Hepatocellular carcinoma (HCC); circRNA-101368

Mesh:

Substances:

Year:  2018        PMID: 30265210      PMCID: PMC6237437          DOI: 10.1080/15384101.2018.1526599

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  19 in total

1.  Microarray profiling of circular RNAs and the potential regulatory role of hsa_circ_0071410 in the activated human hepatic stellate cell induced by irradiation.

Authors:  Yuhan Chen; Baoying Yuan; Zhifeng Wu; Yinying Dong; Li Zhang; Zhaochong Zeng
Journal:  Gene       Date:  2017-07-31       Impact factor: 3.688

2.  High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.

Authors:  Man Chen; Yao Liu; Patrick Varley; Ying Chang; Xing-Xing He; Hai Huang; Daolin Tang; Michael T Lotze; Jusheng Lin; Allan Tsung
Journal:  Cancer Res       Date:  2015-02-26       Impact factor: 12.701

Review 3.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

Review 4.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

5.  High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.

Authors:  Wei Yan; Ying Chang; Xiaoyan Liang; Jon S Cardinal; Hai Huang; Stephen H Thorne; Satdarshan P S Monga; David A Geller; Michael T Lotze; Allan Tsung
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 6.  High-mobility group box 1 and cancer.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

7.  Screening of up- and downregulation of circRNAs in HBV-related hepatocellular carcinoma by microarray.

Authors:  Shichang Cui; Zhiling Qian; Yuhan Chen; Lei Li; Peng Li; Huiguo Ding
Journal:  Oncol Lett       Date:  2017-10-25       Impact factor: 2.967

8.  The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.

Authors:  Huifen Li; Weihua Huang; Rongcheng Luo
Journal:  Diagn Pathol       Date:  2015-07-22       Impact factor: 2.644

9.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.

Authors:  Qiupeng Zheng; Chunyang Bao; Weijie Guo; Shuyi Li; Jie Chen; Bing Chen; Yanting Luo; Dongbin Lyu; Yan Li; Guohai Shi; Linhui Liang; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Nat Commun       Date:  2016-04-06       Impact factor: 14.919

Review 10.  The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.

Authors:  Galina Khemlina; Sadakatsu Ikeda; Razelle Kurzrock
Journal:  Mol Cancer       Date:  2017-08-30       Impact factor: 27.401

View more
  28 in total

Review 1.  Circular RNAs in hepatocellular carcinoma: Recent advances.

Authors:  Zhao-Shan Niu; Wen-Hong Wang
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

Review 2.  Circular RNA as a Novel Biomarker and Therapeutic Target for HCC.

Authors:  Hongwu Meng; Ruowen Niu; Cheng Huang; Jun Li
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

3.  Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.

Authors:  Ling Liu; Xin Yang; Nian-Feng Li; Ling Lin; Hui Luo
Journal:  Cell Cycle       Date:  2019-09-16       Impact factor: 4.534

Review 4.  Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.

Authors:  Yucheng Zhang; Yali Wang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

5.  MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma.

Authors:  Xiao Cui; Dachen Zhou; Qiang Du; Peiqi Wan; Kun Dong; Hui Hou; David A Geller
Journal:  Transl Oncol       Date:  2020-06-17       Impact factor: 4.243

Review 6.  Emerging roles of circRNA in formation and progression of cancer.

Authors:  Yuting Yin; Jiali Long; Qinglian He; Yuling Li; Yanqiu Liao; Peishan He; Wei Zhu
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

7.  Upregulated circRNA ARHGAP10 Predicts an Unfavorable Prognosis in NSCLC through Regulation of the miR-150-5p/GLUT-1 Axis.

Authors:  Mingming Jin; Chunzi Shi; Chen Yang; Jianjun Liu; Gang Huang
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-21       Impact factor: 8.886

8.  circRAPGEF5 Contributes to Papillary Thyroid Proliferation and Metastatis by Regulation miR-198/FGFR1.

Authors:  Weiwei Liu; Ji Zhao; Mingming Jin; Ming Zhou
Journal:  Mol Ther Nucleic Acids       Date:  2019-01-15

Review 9.  Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.

Authors:  Jin-Yu Sun; Xiao-Yu Zhang; Yi-Zhi Cao; Xiao Zhou; Jian Gu; Xiao-Xin Mu
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

Review 10.  Functional roles of circular RNAs during epithelial-to-mesenchymal transition.

Authors:  Bing-Qing Shang; Min-Le Li; Hao-Yu Quan; Ping-Fu Hou; Zhong-Wei Li; Su-Fang Chu; Jun-Nian Zheng; Jin Bai
Journal:  Mol Cancer       Date:  2019-09-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.